BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28215987)

  • 1. Accelerated retinal aging in PACAP knock-out mice.
    Kovács-Valasek A; Szabadfi K; Dénes V; Szalontai B; Tamás A; Kiss P; Szabó A; Setalo G; Reglődi D; Gábriel R
    Neuroscience; 2017 Apr; 348():1-10. PubMed ID: 28215987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary adenylate cyclase-activating polypeptide (PACAP) can act as determinant of the tyrosine hydroxylase phenotype of dopaminergic cells during retina development.
    Borba JC; Henze IP; Silveira MS; Kubrusly RC; Gardino PF; de Mello MC; Hokoç JN; de Mello FG
    Brain Res Dev Brain Res; 2005 May; 156(2):193-201. PubMed ID: 16099306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PACAP-mediated neuroprotection of neurochemically identified cell types in MSG-induced retinal degeneration.
    Atlasz T; Szabadfi K; Kiss P; Babai N; Koszegi Z; Tamas A; Reglodi D; Gabriel R
    J Mol Neurosci; 2008 Nov; 36(1-3):97-104. PubMed ID: 18418735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective Role of Endogenous PACAP in Inflammation-induced Retinal Degeneration.
    Vaczy A; Kovari P; Kovacs K; Farkas K; Szabo E; Kvarik T; Kocsis B; Fulop B; Atlasz T; Reglodi D
    Curr Pharm Des; 2018; 24(30):3534-3542. PubMed ID: 30246634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of the neuropeptide PACAP in diabetic retinopathy.
    Szabadfi K; Atlasz T; Kiss P; Reglodi D; Szabo A; Kovacs K; Szalontai B; Setalo G; Banki E; Csanaky K; Tamas A; Gabriel R
    Cell Tissue Res; 2012 Apr; 348(1):37-46. PubMed ID: 22350850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The presence and distribution of pituitary adenylate cyclase activating polypeptide and its receptor in the snail Helix pomatia.
    Hernádi L; Pirger Z; Kiss T; Németh J; Mark L; Kiss P; Tamas A; Lubics A; Toth G; Shioda S; Reglodi D
    Neuroscience; 2008 Aug; 155(2):387-402. PubMed ID: 18590802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, nitric oxide synthase, and their receptors in human and rat sphenopalatine ganglion.
    Csati A; Tajti J; Kuris A; Tuka B; Edvinsson L; Warfvinge K
    Neuroscience; 2012 Jan; 202():158-68. PubMed ID: 22108610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary adenylate cyclase activating polypeptide-mediated intracrine signaling in the testicular germ cells.
    Li M; Funahashi H; Mbikay M; Shioda S; Arimura A
    Endocrine; 2004 Feb; 23(1):59-75. PubMed ID: 15034198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects.
    Atlasz T; Szabadfi K; Kiss P; Racz B; Gallyas F; Tamas A; Gaal V; Marton Z; Gabriel R; Reglodi D
    Ann N Y Acad Sci; 2010 Jul; 1200():128-39. PubMed ID: 20633141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary Adenylate Cyclase Activating Polypeptide, A Potential Therapeutic Agent for Diabetic Retinopathy in Rats: Focus on the Vertical Information Processing Pathway.
    Szabadfi K; Reglodi D; Szabo A; Szalontai B; Valasek A; Setalo G; Kiss P; Tamas A; Wilhelm M; Gabriel R
    Neurotox Res; 2016 Apr; 29(3):432-46. PubMed ID: 26739825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary adenylyl cyclase-activating polypeptide receptor re-sensitization induces plastic changes in the dopaminergic phenotype in the mature avian retina.
    Fleming RL; Silveira MS; Santos LE; Henze IP; Gardino PF; de Mello MC; de Mello FG
    J Neurochem; 2013 Mar; 124(5):621-31. PubMed ID: 23227973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary adenylyl cyclase-activating polypeptide controls the proliferation of retinal progenitor cells through downregulation of cyclin D1.
    Njaine B; Martins RA; Santiago MF; Linden R; Silveira MS
    Eur J Neurosci; 2010 Aug; 32(3):311-21. PubMed ID: 20646049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Backup Mechanisms Maintain PACAP/VIP-Induced Arterial Relaxations in Pituitary Adenylate Cyclase-Activating Polypeptide-Deficient Mice.
    Ivic I; Fulop BD; Juhasz T; Reglodi D; Toth G; Hashimoto H; Tamas A; Koller A
    J Vasc Res; 2017; 54(3):180-192. PubMed ID: 28490016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) are more susceptible to retinal ischemic injury in vivo.
    Szabadfi K; Atlasz T; Kiss P; Danyadi B; Tamas A; Helyes Z; Hashimoto H; Shintani N; Baba A; Toth G; Gabriel R; Reglodi D
    Neurotox Res; 2012 Jan; 21(1):41-8. PubMed ID: 21717232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution and functional characterization of pituitary adenylate cyclase-activating polypeptide receptors in the brain of non-human primates.
    Jolivel V; Basille M; Aubert N; de Jouffrey S; Ancian P; Le Bigot JF; Noack P; Massonneau M; Fournier A; Vaudry H; Gonzalez BJ; Vaudry D
    Neuroscience; 2009 May; 160(2):434-51. PubMed ID: 19236905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative examination of inner ear in wild type and pituitary adenylate cyclase activating polypeptide (PACAP)-deficient mice.
    Tamas A; Szabadfi K; Nemeth A; Fulop B; Kiss P; Atlasz T; Gabriel R; Hashimoto H; Baba A; Shintani N; Helyes Z; Reglodi D
    Neurotox Res; 2012 May; 21(4):435-44. PubMed ID: 22203609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the protective effects of PACAP with cell-specific markers in ischemia-induced retinal degeneration.
    Atlasz T; Szabadfi K; Kiss P; Tamas A; Toth G; Reglodi D; Gabriel R
    Brain Res Bull; 2010 Mar; 81(4-5):497-504. PubMed ID: 19751807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aging-Induced Modulation of Pituitary Adenylate Cyclase-Activating Peptide- and Vasoactive Intestinal Peptide-Induced Vasomotor Responses in the Arteries of Mice.
    Ivic I; Solymar M; Fulop BD; Hashimoto H; Toth G; Tamas A; Juhasz T; Koller A; Reglodi D
    J Vasc Res; 2017; 54(6):359-366. PubMed ID: 29131060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary adenylyl cyclase-activating polypeptide (PACAP) and its receptor (PAC1-R) are positioned to modulate afferent signaling in the cochlea.
    Drescher MJ; Drescher DG; Khan KM; Hatfield JS; Ramakrishnan NA; Abu-Hamdan MD; Lemonnier LA
    Neuroscience; 2006 Sep; 142(1):139-64. PubMed ID: 16876955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary adenylyl cyclase-activating polypeptide (PACAP) and its receptor (PAC1-R) in the cochlea: evidence for specific transcript expression of PAC1-R splice variants in rat microdissected cochlear subfractions.
    Abu-Hamdan MD; Drescher MJ; Ramakrishnan NA; Khan KM; Toma VS; Hatfield JS; Drescher DG
    Neuroscience; 2006 Jun; 140(1):147-61. PubMed ID: 16626868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.